Sector
PharmaceuticalsOpen
₹243Prev. Close
₹241.9Turnover(Lac.)
₹2.39Day's High
₹243Day's Low
₹23952 Week's High
₹392.552 Week's Low
₹178.05Book Value
₹0Face Value
₹10Mkt Cap (₹ Cr.)
372.44P/E
33.97EPS
7.12Divi. Yield
0Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 13.92 | 5.08 | 1.02 | 1.02 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 43.84 | 16.62 | 11.53 | 6.03 |
Net Worth | 57.76 | 21.7 | 12.55 | 7.05 |
Minority Interest |
No Record Found
No Record Found
No Record Found
Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
---|---|---|---|---|---|
Gross Sales | 135.66 | 114.22 | 99.12 | 70.53 | 38.84 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 135.66 | 114.22 | 99.12 | 70.53 | 38.84 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 1.54 | 1.35 | 0.93 | 0.62 | 0.57 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,698.35 | 129.24 | 4,07,155.15 | 1,181.05 | 0.8 | 5,985.33 | 98.33 |
Divis Laboratories Ltd DIVISLAB | 5,549.7 | 71.05 | 1,47,295.24 | 594 | 0.54 | 2,297 | 513.62 |
Cipla Ltd CIPLA | 1,444.25 | 25.07 | 1,16,664.33 | 1,438.15 | 0.9 | 4,134.87 | 360.73 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,183.9 | 59.03 | 1,07,673.27 | 485 | 0.88 | 2,330 | 222.38 |
Mankind Pharma Ltd MANKIND | 2,458.1 | 52.42 | 1,01,358.17 | 416.38 | 0 | 2,396.57 | 334.17 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
Sanjaykumar Viththalbhai Patel
Executive Director
Pravin Bhadabhai Madhani
Executive Director
Mitesh Lavjibhai Chikhaliya
Independent Director
Keyur Shah
Independent Director
Tarun Ratilal Dobariya
Independent Director
Vaishakhi Ambrishbhai Shukla
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Infinium Pharmachem Ltd
Summary
Infinium Pharmachem Limited was originally incorporated as Infinium Pharmachem Private Limited on November 21, 2003 issued by the Registrar of Companies, Gujarat. Later on, Company converted into Public Company and the name of Company was changed to Infinium Pharmachem Limited vide fresh Certificate of Incorporation dated August 12, 2022 by the RoC, Gujarat. Company was promoted initially by Sanjaykumar Viththalbhai Patel, Pravin Bhadabhai Madhani and others laid down the foundation of the Company in 2003 as a Private Limited in the name of M/s Infinium Pharmachem Private Limited with a vision to establish itself as a globally integrated & admired Pharmaceutical & Healthcare Company. Later on they converted Private Limited into Public Limited Company in the name and style of M/s Infinium Pharmachem Limited (Infinium). The Company was incorporated with the objective of manufacturing and supplying of various pharma related chemicals, bulk drugs, pharma intermediates etc. The Company is engaged in manufacturing and selling of Iodian based Pharmaceutical Intermediates . The Company has its manufacturing plant at Dist. Anand, Gujarat, since inception. The Company was formed with a vision to be globally integrated and admired Pharmaceutical & Healthcare Company,The Companys manufacturing capabilities and technical expertise have catered industries such as Pharmaceutical & Biotech, Specialty & Performance Chemicals, Agrochemicals, Human Health, Animal Health, Cosmetics, Sanitation,
Read More
The Infinium Pharmachem Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹239 today.
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Infinium Pharmachem Ltd is ₹372.44 Cr. as of 01 Apr ‘25
The PE and PB ratios of Infinium Pharmachem Ltd is 33.97 and 3.81 as of 01 Apr ‘25
The 52-week high/low is the highest and lowest price at which a Infinium Pharmachem Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Infinium Pharmachem Ltd is ₹178.05 and ₹392.5 as of 01 Apr ‘25
Infinium Pharmachem Ltd's CAGR for 5 Years at N/I%, 3 Years at N/I%, 1 Year at 5.05%, 6 Month at -35.48%, 3 Month at -22.20% and 1 Month at 8.56%.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.